These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak. Melarangi T; Zhuang J; Lin K; Rockliffe N; Bosanquet AG; Oates M; Slupsky JR; Pettitt AR Cell Death Dis; 2012 Aug; 3(8):e372. PubMed ID: 22898870 [TBL] [Abstract][Full Text] [Related]
4. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation, and Mcl-1 elimination. Gómez-Benito M; Marzo I; Anel A; Naval J Mol Pharmacol; 2005 Jun; 67(6):1991-8. PubMed ID: 15738311 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced apoptosis in chronic lymphocytic leukemia. Stoetzer OJ; Pogrebniak A; Scholz M; Pelka-Fleischer R; Gullis E; Darsow M; Nüssler V; Wilmanns W Leukemia; 1999 Nov; 13(11):1873-80. PubMed ID: 10557065 [TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. Bellosillo B; Villamor N; Colomer D; Pons G; Montserrat E; Gil J Blood; 1999 Oct; 94(8):2836-43. PubMed ID: 10515887 [TBL] [Abstract][Full Text] [Related]
7. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396 [TBL] [Abstract][Full Text] [Related]
8. Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Choi S; Singh SV Cancer Res; 2005 Mar; 65(5):2035-43. PubMed ID: 15753404 [TBL] [Abstract][Full Text] [Related]
9. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352 [TBL] [Abstract][Full Text] [Related]
10. The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs. Paulus A; Masood A; Miller KC; Khan AN; Akhtar D; Advani P; Foran J; Rivera C; Roy V; Colon-Otero G; Chitta K; Chanan-Khan A Br J Haematol; 2014 Apr; 165(1):78-88. PubMed ID: 24467634 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. Sundararajan R; Cuconati A; Nelson D; White E J Biol Chem; 2001 Nov; 276(48):45120-7. PubMed ID: 11571294 [TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis. Siegmund B; Welsch J; Loher F; Meinhardt G; Emmerich B; Endres S; Eigler A Leukemia; 2001 Oct; 15(10):1564-71. PubMed ID: 11587214 [TBL] [Abstract][Full Text] [Related]
13. Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells. Han J; Goldstein LA; Gastman BR; Rabinovitz A; Wang GQ; Fang B; Rabinowich H Leukemia; 2004 Oct; 18(10):1671-80. PubMed ID: 15356645 [TBL] [Abstract][Full Text] [Related]
14. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. Byrd JC; Shinn C; Waselenko JK; Fuchs EJ; Lehman TA; Nguyen PL; Flinn IW; Diehl LF; Sausville E; Grever MR Blood; 1998 Nov; 92(10):3804-16. PubMed ID: 9808574 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. Ray S; Almasan A Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654 [TBL] [Abstract][Full Text] [Related]
16. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435 [TBL] [Abstract][Full Text] [Related]
17. Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells. Han CR; Jun do Y; Lee JY; Kim YH Apoptosis; 2014 Jan; 19(1):224-40. PubMed ID: 24166139 [TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Panaretakis T; Pokrovskaja K; Shoshan MC; Grandér D Oncogene; 2003 Jul; 22(29):4543-56. PubMed ID: 12881711 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide. Amigo-Jiménez I; Bailón E; Ugarte-Berzal E; Aguilera-Montilla N; García-Marco JA; García-Pardo A PLoS One; 2014; 9(6):e99993. PubMed ID: 24956101 [TBL] [Abstract][Full Text] [Related]